Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Crinetics Pharmaceuticals Inc banner

Crinetics Pharmaceuticals Inc
SWB:6Z4

Watchlist Manager
Crinetics Pharmaceuticals Inc Logo
Crinetics Pharmaceuticals Inc
SWB:6Z4
Watchlist
Price: 72.64 EUR -0.08%
Market Cap: €2.4B
Write Note Create Alert Ask AI

Wall St Price Targets

6Z4 Price Targets Summary
Crinetics Pharmaceuticals Inc

Wall Street analysts forecast 6Z4 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 6Z4 is 73.35 EUR with a low forecast of 58.8 EUR and a high forecast of 85.4 EUR.

6Z4 Lowest Forecast
Wall Street Target
€58.8
-19% Downside
6Z4 Average Forecast
Wall Street Target
€73.35
1% Upside
6Z4 Highest Forecast
Wall Street Target
€85.4
18% Upside
Lowest Forecast
Price Target
58.8 EUR
19% Downside
Average Forecast
Price Target
73.35 EUR
1% Upside
Highest Forecast
Price Target
85.4 EUR
18% Upside
Crinetics Pharmaceuticals Inc Competitors:
Price Targets
EBMT
Eagle Bancorp Montana Inc
11% Upside
VAC
Pierre et Vacances SA
15% Upside
INBK
First Internet Bancorp
12% Upside
D
DSS
Dss Inc
463% Upside
EBMT
Eagle Bancorp Montana Inc
11% Upside
VAC
Pierre et Vacances SA
15% Upside
INBK
First Internet Bancorp
12% Upside
D
DSS
Dss Inc
463% Upside
CENT
Central Garden & Pet Co
14% Upside
NWSA
News Corp
15% Upside
SDGR
Schrodinger Inc
-4% Downside

Revenue
Forecast

18% / Year
Past Growth
123% / Year
Estimated Growth
Estimates Accuracy
9%
Average Beat
18% / Year
Past Growth
123% / Year
Estimated Growth
Estimates Accuracy
9%
Average Beat

Over the last 8 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 8 years is 123%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
125% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
125% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Gross Profit over the next 8 years is 125%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

What are analyst estimates?

Continue 6Z4 Research

Summary
6Z4 intrinsic value, competitors valuation, and company profile.
DCF Valuation
6Z4 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
6Z4 stock valuation using valuation multiples.
Wall St Estimates
6Z4 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
6Z4 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Crinetics Pharmaceuticals Inc listings:
NASDAQ • USD
CRNX
 F • EUR
6Z4
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 6Z4's stock price target?
Price Target
73.35 EUR

According to Wall Street analysts, the average 1-year price target for 6Z4 is 73.35 EUR with a low forecast of 58.8 EUR and a high forecast of 85.4 EUR.

What is the Revenue forecast for Crinetics Pharmaceuticals Inc?
Projected CAGR
123%

Over the last 8 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 8 years is 123%.

What is the Gross Profit forecast for Crinetics Pharmaceuticals Inc?
Projected CAGR
125%

The compound annual growth rate for Gross Profit over the next 8 years is 125%.

Back to Top
ALPHA SPREAD
Follow us
Join 355,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett